We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Avacta | LSE:AVCT | London | Ordinary Share | GB00BYYW9G87 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.75 | 1.73% | 44.00 | 43.00 | 45.00 | 44.00 | 43.25 | 43.25 | 317,337 | 08:19:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 23.25M | -24.95M | -0.0695 | -6.33 | 155.29M |
Date | Subject | Author | Discuss |
---|---|---|---|
12/9/2024 18:05 | Certainly one for the GRAND OLD DUKE OF YORK | waldron | |
12/9/2024 17:47 | Technical analysis trend Short Term Mid-Term Long Term Resistance 77.00 82.50 154.00 Support 65.00 39.75 40.25 Certainly could do with more Analysts covering the company | waldron | |
12/9/2024 17:42 | Investor Presentation via Investor Meet Company Avacta Group plc (AIM: AVCT), a life sciences company developing innovative, targeted cancer treatments and powerful diagnostics, will announce its unaudited interim results on 30 September 2024 for the six months ended 30 June 2024. Christina Coughlin, MD, PhD, Avacta's CEO, will discuss the results and the Company's operational and clinical progress via the Investor Meet Company platform on 30 September 2024 at 11:00 BST. The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via your Investor Meet Company dashboard up until 29 September 2024, 09:00 BST, or at any time during the live presentation. Investors can sign up to Investor Meet Company for free and add to meet AVACTA GROUP PLC via: Investors who already follow Avacta on the Investor Meet Company platform will automatically be invited. The Company will also post its results presentation on its website at the following page: | waldron | |
12/9/2024 16:21 | Results could be interesting? Short @ 74p. | dudishes | |
12/9/2024 16:03 | The exact opposite.....CC wants to remain independent but Avacta can only do that by listing on Nasdaq. No other reason to appoint Darlene Deptula-Hicks. But the CEO is not alone and the twenty or so very senior people running Avacta and the Scientific Advisory Board all want a slice of the fame barreling their way. | vertizeasun | |
12/9/2024 15:47 | But Chesh, why has Agent Smith disappeared in a puff of smoke. I think there are 2 possible reasons a/ poor guy is ill b/ something is wrong with the data,trials etc. Sorry Chesh,I just can't get past this key point. Aim smells. You may call me a Fudster but I.m not fully convinced yet. If they can deliver more modern warheads, the game will defo be on. The Doli delivery is clearly great, but a better warhead(s) may be necessary. I think they want to be taken over ... | amanitaangelicus | |
12/9/2024 12:58 | Having held Avacta for several years, I've come to realise that there are two ways to track the progress of the company. First, the obvious one, the RNS's released by the company and the share price. The second, more subtle, is the change in the narrative of the FUDsters. Instead of continual, often contrived posts about AVA6k not working or feigned concern about the Heights CLN, we are now getting some along the lines of it may work but others including big pharma are already further along the track. Laughable. Keep trying guys. Holding my shares, you haven't persuaded me to sell. | cheshire pete | |
12/9/2024 11:35 | JakNife, BF not there yet why not ? I suspect sabotage of Avacta share price as vested interests at play! Happy to hold | fieldhouse | |
12/9/2024 11:35 | JakNife, BF not there yet why not ? I suspect sabotage of Avacta share price as vested interests at play! Happy to hold | fieldhouse | |
12/9/2024 10:08 | fieldhouse1 "The potential for Avacta’s targeted warhead get’s more relevant by the day It could be the saviour of the NHS" Guess what you get if you type "targeted cancer warhead" into Google. You don't get pages for AVA 6000, that's for sure! Try it and you'll have your eyes opened, you'll find: * Numerous large pharma companies already have targeted cancer therapies, not just ones in Phase 1 trials but ones that have been approved by the FDA and are on sale now. * The likes of AstraZeneca are spending $1.5bn to build a brand new factory in Singapore to manufacture their "next-generation treatments that deliver highly potent cancer-killing agents directly to cancer cells through a targeted antibody". * Despite the wildest of wild claims by Avacta's shareholders actually Big Pharma already has tech that is miles better than Avacta's and hence they have absolutely no reason whatsoever to be interested in acquiring/partnering with Avacta. JakNife | jaknife | |
12/9/2024 09:45 | The NHS report is out today and highlights the unacceptable number of deaths from cancer !! The potential for Avacta’s targeted warhead get’s more relevant by the day . It could be the saviour of the NHS Now there’s a thought ! | fieldhouse | |
12/9/2024 08:47 | Let's not forget about the pipeline of assets to be announced imminently as well. Plenty to look forward to here. Like I said, it's all looking rosy. | rajraj b | |
12/9/2024 08:05 | Looks like Avacta have been fishing with a line and have now trawled a whole shoal !! | fieldhouse | |
12/9/2024 06:22 | When was this recorded | carlsberg | |
12/9/2024 06:15 | Well if I was sat on the sidelines I know what I would do | jacktrax | |
11/9/2024 20:58 | 24,000 views today. Certainly showing some interest. | rajraj b | |
11/9/2024 14:18 | Very good science . On generation 3 of av6000 Not just a general hit at the tumour, but targeted and guided like a precision guided missile . The team have been busy | fieldhouse | |
11/9/2024 12:43 | AI ...gene therapy ...simples. | amanitaangelicus | |
11/9/2024 07:30 | Many thanks for the link Cheshire Pete. Very informative indeed. | bbd2 | |
11/9/2024 05:48 | Still no word from TimeLord Smith. Just what did he do? Gone- without a word. Sold his shares? Delays galore. | amanitaangelicus | |
11/9/2024 05:43 | Yes seen it, we shall see if things really hot up before end next month won't hold me breath seen this spin so many times | repins1 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions